LOS ANGELES, Aug. 21 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. (“China Pharma”) , a leading specialty bio-pharmaceutical company that develops, manufactures, and markets generic and brand products in China announced today that its Vice President, Strategic Planning and Business Development, Donald Xu, and Chief Financial Officer, Xinhua Wu will present at the upcoming Roth Capital Partners 2006 New York Conference.
The Roth Capital Partners Conference features presentations from over 200 small and micro cap companies with a focus on undiscovered companies as well as international companies that aren’t well known to U.S. investors in the technology, healthcare, financial services and consumer products sectors.
Date: Thursday, September 7, 2006 Time: 1:30 PM Eastern Time Venue: The Westin Times Square Hotel, New York Live webcast: http://www.rothconference.com /
A replay of the webcast will be available for 60 days at: http://www.rothconference.com/
Interested parties and institutional investors may register for the conference by visiting the conference website at http://www.rothconference.com/ or by calling Roth Capital Partners at (800) 678-9147.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty bio-pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
China Pharma Holdings, Inc.
CONTACT: Donald Xu of China Pharma Holdings, Inc., +1-858-776-8880,dxu@chinapharmaholdings.com; Investor Relations, Crocker Coulson,+1-310-477-9800, ext. 103, crocker.coulson@ccgir.com
Web site: http://www.rothconference.com/
